Literature DB >> 20128002

Treatment-associated acute myeloid leukemia in a patient with Crohn's disease on 6-mercaptopurine.

Koushik K Das, Ha Thanh Nishino, Andrew T Chan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20128002      PMCID: PMC2930092          DOI: 10.1002/ibd.21205

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


× No keyword cloud information.
  9 in total

1.  Concurrent inflammatory bowel disease and myelodysplastic syndromes.

Authors:  G C Harewood; E V Loftus; A Tefferi; W J Tremaine; W J Sandborn
Journal:  Inflamm Bowel Dis       Date:  1999-05       Impact factor: 5.325

Review 2.  Development of acute myelocytic leukemia in patients with Crohn's disease.

Authors:  L Halme; J von Knorring; E Elonen
Journal:  Dig Dis Sci       Date:  1990-12       Impact factor: 3.199

3.  The ten-year single-center experience with 6-mercaptopurine in the treatment of inflammatory bowel disease.

Authors:  Kenneth D Glazier; Adam L Palance; Louis H Griffel; Kiron M Das
Journal:  J Clin Gastroenterol       Date:  2005-01       Impact factor: 3.062

4.  Acute leukemia following inflammatory bowel disease.

Authors:  S B Hanauer; K K Wong; P H Frank; D L Sweet; J B Kirsner
Journal:  Dig Dis Sci       Date:  1982-06       Impact factor: 3.199

5.  Acute myelogenous leukemia in patients with ulcerative colitis.

Authors:  T L Fabry; D B Sachar; H D Janowitz
Journal:  J Clin Gastroenterol       Date:  1980-09       Impact factor: 3.062

6.  Possible carcinogenic effect of 6-mercaptopurine on bone marrow stem cells: relation to thiopurine metabolism.

Authors:  J Bo; H Schrøder; J Kristinsson; B Madsen; C Szumlanski; R Weinshilboum; J B Andersen; K Schmiegelow
Journal:  Cancer       Date:  1999-09-15       Impact factor: 6.860

7.  Acute myeloblastic leukemia following prolonged treatment of Crohn's disease with 6-mercaptopurine.

Authors:  W D Heizer; J L Peterson
Journal:  Dig Dis Sci       Date:  1998-08       Impact factor: 3.199

Review 8.  Etiology and management of therapy-related myeloid leukemia.

Authors:  Richard A Larson
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2007

Review 9.  Lymphoma risk in inflammatory bowel disease: is it the disease or its treatment?

Authors:  Jennifer L Jones; Edward V Loftus
Journal:  Inflamm Bowel Dis       Date:  2007-10       Impact factor: 5.325

  9 in total
  3 in total

Review 1.  Acute myeloid leukemia developing in patients with autoimmune diseases.

Authors:  Safaa M Ramadan; Tamer M Fouad; Valentina Summa; Syed Kh Hasan; Francesco Lo-Coco
Journal:  Haematologica       Date:  2011-12-16       Impact factor: 9.941

2.  Azathioprine-associated myelodysplastic syndrome in two patients with ulcerative colitis.

Authors:  Omer F Ahmad; Margaret G Keane; Sara McCartney; Asim Khwaja; Stuart L Bloom
Journal:  Frontline Gastroenterol       Date:  2013-03-20

3.  Medical conditions and risk of adult myeloid leukemia.

Authors:  Kimberly J Johnson; Cindy M Blair; James M Fink; James R Cerhan; Michelle A Roesler; Betsy A Hirsch; Phuong L Nguyen; Julie A Ross
Journal:  Cancer Causes Control       Date:  2012-05-11       Impact factor: 2.506

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.